Financials
- Market Capitalization 519.43 M
- Employee 22
- Founded 2009
- CEO N/A
- Website www.enterabio.com
- Headquarter Israel
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
5.21
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2883 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.43 USD | -5.07% | -13.12% | -0.55% | +170.15% | 520.35 M USD | ||
| 2885 | OVID Ovid Therapeutics Inc. - Common Stock | 2.68 USD | -4.29% | -4.96% | +20.72% | +114.40% | 523.40 M USD | ||
| 2895 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.39 USD | +0.24% | +1.57% | +15.72% | +133.70% | 518.87 M USD | ||
| 2940 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -5.57% | +18.67% | -23.67% | 479.78 M USD |